Progesterone receptor membrane component 1 as the mediator of the inhibitory effect of progestins on cytokine-induced matrix metalloproteinase 9 activity in vitro

Reproductive Sciences

Volumn 21, Issue 2, 2014, Pages 260-268

  Allen, Terrence K ^a   Feng, Liping ^a   Grotegut, Chad A ^a   Murtha, Amy P ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

inflammation; preterm delivery; progesterone; progesterone receptor

Indexed keywords

DEXAMETHASONE; GELATINASE B; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CHORION; CONTROLLED STUDY; CYTOTROPHOBLAST; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FETUS; FETUS MEMBRANE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; MEMBRANE COMPONENT; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

INFLAMMATION; PRETERM DELIVERY; PROGESTERONE; PROGESTERONE RECEPTOR;

CELL LINE; CHORION; CYTOKINES; ENZYME ACTIVATION; EXTRAEMBRYONIC MEMBRANES; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; PROGESTINS; RECEPTORS, PROGESTERONE;

EID: 84898596400     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113493514     Document Type: Article

References (32)

1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008 ; 371 ((9606)). 75-84
2. George RB, Kalich J, Yonish B, Murtha AP. Apoptosis in the chorion of fetal membranes in preterm premature rupture of membranes. Am J Perinatol. 2008 ; 25 (1). 29-32
3. Fortunato SJ, Menon R, Lombardi SJ. Amniochorion gelatinase-gelatinase inhibitor imbalance in vitro: a possible infectious pathway to rupture. Obstet Gynecol. 2000 ; 95 (2). 240-244
4. Fortunato SJ, Menon R, Lombardi SJ. Role of tumor necrosis factor α in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol. 2002 ; 187 (5). 1159-1162
5. Fortunato SJ, Menon R. Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. Am J Obstet Gynecol. 2001 ; 184 (7). 1399-1406
6. Xu P, Alfaidy N, Challis JR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab. 2002 ; 87 (3). 1353-1361
7. Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011 ; 38 (1). 18-31
8. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003 ; 348 (24). 2379-2385
9. Guoyang Luo, Abrahams VM, Tadesse S, et al. Progesterone inhibits basal and TNFα-induced apoptosis in fetal membranes: a novel mechanism to explain progesterone-mediated prevention of preterm birth. Reprod Sci. 2010 ; 17 (6). 532-539
10. Oner C, Schatz F, Kizilay G, et al. Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J Clin Endocrinol Metabol. 2008 ; 93 (1). 252-259
11. Murtha AP, Feng L, Yonish B, Leppert PC, Schomberg DW. Progesterone protects fetal chorion and maternal decidua cells from calcium-induced death. Am J Obstet Gynecol. 2007 ; 196 (3). e251 - e257
12. Merlino A, Welsh T, Erdonmez T, et al. Nuclear progesterone receptor expression in the human fetal membranes and decidua at term before and after labor. Reprod Sci. 2009 ; 16 (4). 357-363
13. Goldman S, Weiss A, Almalah I, Shalev E. Progesterone receptor expression in human decidua and fetal membranes before and after contractions: possible mechanism for functional progesterone withdrawal. Mol Hum Reprod. 2005 ; 11 (4). 269-277
14. Chappell PE, Lydon JP, Conneely OM, O'Malley BW, Levine JE. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. Endocrinology. 1997 ; 138 (10). 4147-4152
15. Peluso JJ. Non-genomic actions of progesterone in the normal and neoplastic mammalian ovary. Semin Reprod Med. 2007 ; 25 (3). 198-207
16. Falkenstein E, Schmeiding K, Lange A, et al. Localization of a putative progesterone membrane binding protein in porcine hepatocytes. Cell Mol Biol (Noisy-le-grand). 1998 ; 44 (4). 571-578
17. Peluso JJ, Romak J, Liu X. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology. 2008 ; 149 (2). 534-543
18. Graham CH, Hawley TS, Hawley RC, et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res. 1993 ; 206 (2). 204-211
19. Kumar D, Fung W, Moore RM, et al. Proinflammatory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes. Biol Reprod. 2006 ; 74 (1). 29-34
20. Li W, Li H, Bocking AD, Challis JR. Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway. Biol Reprod. 2010 ; 83 (3). 481-487
21. Kumar D, Schatz F, Moore RM, et al. The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitro. Placenta. 2011 ; 32 (3). 206-213
22. Kilburn BA, Wang J, Duniec-Dmuchkowski ZM, Leach RE, Romero R, Armant DR. Extracellular matrix composition and hypoxia regulate the expression of HLA-G and Integrins in a human trophoblast cell line. Biol Reprod. 2000 ; 62 (3). 739-747
23. Moore RM, Schatz F, Kumar D, et al. Alpha-lipoic acid inhibits thrombin-induced fetal membrane weakening in vitro. Placenta. 2010 ; 31 (10). 886-892
24. Peluso JJ, DeCerbo J, Lodde V. Evidence for a genomic mechanism of action for progesterone receptor membrane component-1. Steroids. 2012 ; 77 (10). 1007-1012
25. Arici A, Marshburn PB, MacDonald PC, Dombrowski RA. Progesterone metabolism in human endometrial stromal and gland cells in culture. Steroids. 1999 ; 64 (8). 530-534
26. Manuck TA, Lai Y, Meis PJ, et al. Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol. 2011 ; 205 (2). e1-135
27. Stopiska-Guszak U, Waligóra J, Grzela T, et al. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol. 2006 ; 69 (1). 65-75
28. Sitruk-Ware R. New progestagens for contraceptive use. Human Reprod Update. 2006 ; 12 (2). 169-178
29. Kontula K, Paavonen T, Luukkainen T, Andersson LC. Binding of progestins to the glucocorticoid receptor: correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol. 1983 ; 32 (9). 1511-1518
30. Beppu M, Ikebe T, Shirasuna K. The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-κB-mediated protease production by oral cancer. Biochim Biophys Acta. 2002 ; 1586 (1). 11-22
31. Ruan X, Neubauer H, Yang Y, et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric. 2012 ; 15 (5). 467-72
32. Neubauer H, Yang Y, Seeger H, et al. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells. Menopause. 2011 ; 18 (8). 845-850